<DOC>
	<DOC>NCT00293046</DOC>
	<brief_summary>This trial is performed to assess whether the Grazax® treatment compliance can be improved by use of a compliance device (Memozax®).</brief_summary>
	<brief_title>Assessment of Grazax® Treatment Compliance</brief_title>
	<detailed_description />
	<criteria>Grass pollen induced rhinoconjunctivitis Males and females, 1865 years of age Positive skin prick test Previous treatment with grass pollen allergen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Allergy</keyword>
</DOC>